Your company earned the revenue. The margin should follow. But between the invoice and the bank account, two distinct categories of loss are working against you simultaneously.
Internal bleed is the money your company loses to its own inefficiency — the costs that never appear as a line item because they are absorbed into normal operations.
External bleed is the money your company loses to the market, to customers and to counterparties — the discounts approved, the terms conceded, the pricing power surrendered.
Most CEOs are aware of one or the other. Very few have priced both at the same time. Fewer still have addressed both with a single, coordinated intervention. The result is a margin that is smaller than it should be, for reasons that are never fully explained.
Internal Bleed: The Invisible Tax on Your Own Operations
Internal bleed is the hardest category to see because it never appears as a single line item on the P&L. It shows up as a slightly lower gross margin than the model predicted. As a payroll cost that is higher than the headcount justifies. As a project that took 30% longer than the estimate and nobody is sure why.
The money is gone, but there is no invoice to point to. The loss is distributed across dozens of small decisions, delays and failures that individually look like normal business friction.
The most common sources of internal bleed in manufacturing:
- Unbilled scope delivered to keep a customer happy, with no change order raised
- Rework and scrap absorbed into the production cost line rather than reported separately
- Downtime logged as maintenance rather than as lost production value
- Overtime approved to meet a deadline that was missed due to a planning failure
A single example, priced:
> A production team delivers a custom modification that was not in the original contract. The sales team approved it verbally. Nobody billed for it. The modification took 40 hours of engineering time. At a fully loaded cost of $80 per hour, that is $3,200 given away on one job. Multiply across 50 jobs per year: $160,000 in internal bleed from one source alone.
In technology companies, internal bleed concentrates differently:
- Wasted R&D on features that no paying customer requested
- Misallocated executive time on work that does not move revenue
- Technical debt that slows every subsequent delivery and is never costed
- Scope creep absorbed by the engineering team without a change order
A product team spends three months building a feature that two enterprise customers requested. The feature ships. Neither customer upgrades. At a fully loaded cost of $15,000 per engineer per month, that is $135,000 in internal bleed for a three-person team. The feature is on the roadmap. The cost is not on the P&L.
External Bleed: The Accepted Cost That Compounds Quietly
External bleed is more visible but more accepted. Contract penalties appear on the P&L, but they are categorised as one-off costs rather than systemic losses. Unnecessary discounts are approved by sales managers who are measured on closed revenue, not on margin. Overpriced supplier contracts are renewed annually because the procurement team does not have the bandwidth to renegotiate.
Each of these is a decision that could be changed. None of them are being changed because nobody has priced the cumulative cost.
The most dangerous form of external bleed is customer concentration. When a single customer represents more than 15% of your revenue, that customer has pricing power over you. Their procurement team uses it systematically:
- Every renewal conversation opens with a request for a discount
- Every delay in their payment cycle is tolerated because you cannot afford to lose them
- Every additional scope request is delivered because the relationship feels too important to protect
The discount you give them is external bleed. The extended payment terms you accept are external bleed. The additional scope you deliver to keep them happy is internal bleed. One customer is generating losses in both categories simultaneously — and the total cost is almost never calculated.
Why Both Must Be Addressed Together
The reason most companies do not address both categories simultaneously is that they require different interventions — and those interventions sit in different functions with different incentives.
Internal bleed requires operational discipline:
- Sign-off rules that prevent unbilled scope from being delivered
- Tracking systems that surface rework as a dollar figure, not a defect rate
- Accountability structures that make the cost of poor quality visible to the CEO monthly
External bleed requires commercial discipline:
- Pricing authority that prevents discounts from being approved below a margin floor
- Contract terms that protect the business from concentration risk
- Customer diversification programmes that reduce dependency before it becomes a crisis
The CEO is the only person in the company with the authority and the perspective to address both simultaneously. But as companies grow, CEOs lose the visibility needed to see both categories clearly — which is precisely when the losses accelerate.
The Combined Cost: What the Numbers Look Like
For a manufacturing or technology business with $10M in annual revenue, a conservative estimate of combined bleed:
| Category | Annual Loss |
|---|---|
| Unbilled scope and rework | $200,000 – $400,000 |
| Customer concentration discounts | $150,000 – $300,000 |
| Overpriced supplier contracts | $50,000 – $150,000 |
| Wasted R&D and misallocated executive time | $100,000 – $250,000 |
| Total | $500,000 – $1,100,000 |
That is 5–11% of revenue leaving the business through leaks that have never been priced and never been addressed. On a 6x EBITDA multiple, the enterprise value impact of recovering that margin is $3M to $6.6M.
How the Executive Leak Assessment Maps Both Categories
The Executive Leak Assessment maps both internal and external bleed for your specific business. It identifies the five to ten largest leaks, prices each one in money, and recommends the engagement that addresses the highest-value losses first.
The output is not a general framework. It is a specific, priced list of the losses your company is sustaining right now — with the actions required to stop them.
*Two weeks. A priced report of where your margin is going. Request the Executive Leak Assessment and find out what both categories are costing you.*
About the Author
M.K. Hasan
Founder, EVOSYST · Global CHRO & Strategic Advisor to CEOs
M.K. Hasan helps CEOs and Boards find the revenue their business is losing and get it back. He works across Strategy, People and Operations through focused diagnostic and recovery sprints.
Request an Executive Leak Assessment